Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data
Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries
Publication
, Chapter
Otero, CE; Langel, SN; Blasi, M; Permar, SR
January 1, 2021
Duke Scholars
Publication Date
January 1, 2021
Start / End Page
217 / 228
Citation
APA
Chicago
ICMJE
MLA
NLM
Otero, C. E., Langel, S. N., Blasi, M., & Permar, S. R. (2021). Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries. In Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data (pp. 217–228).
Otero, C. E., S. N. Langel, M. Blasi, and S. R. Permar. “Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries.” In Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data, 217–28, 2021.
Otero CE, Langel SN, Blasi M, Permar SR. Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries. In: Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data. 2021. p. 217–28.
Otero, C. E., et al. “Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries.” Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data, 2021, pp. 217–28.
Otero CE, Langel SN, Blasi M, Permar SR. Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries. Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data. 2021. p. 217–228.
Publication Date
January 1, 2021
Start / End Page
217 / 228